참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | (+-)-2-Butanol | HCID 6568 | — |
| 반응물 | 6-Chloropurine | HCID 5359277 | — |
| 반응물 | (6-Phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methanamine | HCID 67501979 | — |
| 생성물 | N-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-7H-purin-6-amine | HCID 57691174 | 32.8% |
반응 단계
A 15 mL tube was charged with (6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methanamine (0.100 g, 0.444 mmol), 6-chloropurine (0.103 g, 0.666 mmol), and sec-butanol (3.00 ml, 32.4 mmol), sealed, then heated in a 100° C. oil bath for 5 hours. The reaction mixture was concentrated and the yellow residue was purified by MPLC using a 40 g RediSep column, eluting with a gradient of 3-8% MeOH/DCM over 80 minutes. N-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-7H-purin-6-amine (0.0500 g, 32.8% yield) was isolated as the hydrochloride salt.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08524900B2 |
|---|
| 출처 데이터셋 | uspto-grants-2013_09 |
|---|
| ORD ID | ord-9906acc1e70341139e36a3119039e418 |
|---|
| 출처 메모 | uspto-grants-2013_09 |
|---|